The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit.
NCT06882408 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 315
Last updated 2025-04-29
Summary
The goal of this clinical trial is to evaluate the performance of a photorefraction screener in terms of sensibility, sensitivity and accuracy on children aged 3 to 8 y.o. The main objectives of the study are:
* Evaluate the performances of the device in comparison with the gold standard, i.e. a tabletop refractometer.
* Assess the agreement of the measures obtained with the device with those obtained with the gold standard.
Conditions
- Ametropia
- Myopia; Refractive Error
- Myopia; Astigmatism
Interventions
- DEVICE
-
Photorefraction device under investigation
Objective refraction measurement with and without cyclopegia
- DEVICE
-
Comparator device, Tabletop auto-refractometer
Objective refraction measurement with and without cyclopegia
- DEVICE
-
Comparator device, portable photorefraction device
Objective refraction measurement with and without cyclopegia
- OTHER
-
Distance visual acuity assessments
Distance visual acuity is assessed with the refraction measures found by the device under investigation and the comparator device with and without cyclopegia.
- OTHER
-
Subjective refraction and far visual acuity
Subjective refraction is assessed and far visual acuity is assessed with the found refraction measures
- OTHER
-
Strabismus assessment
Strabismus is assessed with the refraction measures found by the device under investigation and the comparator device with and without cyclopegia.
Sponsors & Collaborators
-
Essilor International
lead INDUSTRY
Principal Investigators
-
Aranaud Sauer, MD, PhD, FEBO · Hôpital Civil de Strasbourg
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Max Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-04-30
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- France
Study Locations
More Related Trials
-
Myopia Control: a Comparison Study Between Atropine and MiSight
NCT05815784 ·Status: RECRUITING ·Phase: PHASE2
-
Study in Pediatric Volunteers of a Handheld Device Versus a Standard Diagnostic Device in Ophthalmic Refraction
NCT04955379 ·Status: UNKNOWN ·Phase: NA
-
A Trial of Bifocals in Myopic Children With Esophoria
NCT00000128 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of AmblyoFix for the Treatment of Unilateral Amblyopia
NCT07240311 ·Status: TERMINATED ·Phase: NA
-
Comparing Preschool-Aged Refractive Measurements and Amblyopia Risks Using the 2WIN-S Portable Refractor with Vision Screening by Cycloplegic Refraction in Bangkok
NCT06148519 ·Status: TERMINATED ·Phase: NA
-
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
NCT06034327 ·Status: RECRUITING ·Phase: NA
-
First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
NCT01365884 ·Status: TERMINATED
-
Optimization of a Photoretinoscopy Method for Determining the Objective Refraction of Children With a Smartphone/add-on Device in India
NCT06524115 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Visual Screening in Ontario
NCT02458846 ·Status: COMPLETED ·Phase: NA
-
Is Non-cycloplegic Photorefraction Applicable for Screening Refractive Risk Factors of Amblyopia?
NCT01308307 ·Status: COMPLETED ·Phase: PHASE2
-
Luminopia One Amblyopia Vision Improvement Study
NCT03608150 ·Status: COMPLETED ·Phase: NA
-
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
NCT06380517 ·Status: RECRUITING ·Phase: PHASE3
-
EyeQue VisionCheck 510(k) Clinical Trial
NCT06044688 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression
NCT05331378 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic Subjects
NCT06075576 ·Status: COMPLETED
-
Amblyopia Treatment for Children Aged 8 to 12 Years
NCT07281742 ·Status: RECRUITING ·Phase: NA
-
Comparison of Photorefraction With Cycloautorefraction and Cycloretinoscopy at Emam Hosein Medical Centre in 2008-2009
NCT00815581 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Evaluation of Safety and Myopia Progression Control Using Novel Spectacle Lens
NCT05886348 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Orthokeratology on Myopia Progression in French Children
NCT05700240 ·Status: COMPLETED
-
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
NCT06927414 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Bilateral and Unilateral Amblyopia Treatment Study
NCT03780205 ·Status: TERMINATED
-
A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children
NCT00347581 ·Status: COMPLETED ·Phase: PHASE3
-
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
NCT07095894 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Effect of Early Glasses on the Development of Amblyopia
NCT04740593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Refractive Status and Accommodation Response Under Different Experimental Conditions.
NCT06331780 ·Status: RECRUITING ·Phase: NA